Recruiting US Biotech Talent to Canada | Canadian Biotech

Canada's Ongoing Pursuit of STEM Talent

During the presidency of Donald Trump, Canada gained attention for its initiatives aimed at attracting STEM professionals. Despite the change in U.S. administration, Canada continues its efforts to recruit skilled workers, with biotechnology emerging as a key area of focus in this competitive landscape.

A Shift in Competitive Advantage

Historically, Canadian engineers, programmers, and researchers often found the higher salaries and favorable climate of Silicon Valley appealing. However, the four years of anti-immigration policies, rhetoric, and visa restrictions under Trump provided a distinct advantage to Canadian tech companies and governmental bodies.

Government Initiatives and Industry Response

Following 2016, the Canadian federal government actively bolstered the tech sectors in cities like Toronto, Montreal, and Vancouver. This was achieved through the implementation of a program designed to expedite the immigration process.

Canadian tech industry leaders enthusiastically supported these efforts, launching campaigns to encourage workers to relocate north. Notably, even Quebec, traditionally cautious regarding immigration, was persuaded to increase its intake of newcomers by as much as 14%.

The Impact of the Pandemic and Changing Trends

The pandemic-induced migration away from Silicon Valley has resulted in a significant return of Canadian expatriates. Simultaneously, applications from Canadians for the U.S. H-1B visa program have decreased substantially, continuing a trend observed over the past decade.

Continued Concerns and Strategic Focus

Despite these positive developments, both Canadian tech and political leaders remain focused on attracting talent to crucial sectors, including advanced manufacturing, clean technology, and biotechnology.

They are actively pursuing all available avenues to diminish the longstanding advantages held by the United States.

Biotechnology as a Priority Sector

A significant portion of this effort is concentrated within the biotechnology field. The COVID-19 pandemic highlighted Canada’s limited vaccine production capabilities.

However, the country possesses a robust biotechnology and life-sciences research sector, supported by a strong university system and numerous startup companies engaged in pioneering research.

Many of these companies benefited from the surge in biotech investment during the pandemic, securing record levels of venture capital in 2020.

Challenges in Scaling and Talent Acquisition

While funding has increased, many Canadian companies still face challenges in achieving substantial scale. The Canadian tech ecosystem, while rich in talent, has historically struggled to develop, recruit, and retain sufficient senior-level personnel needed for these firms to become global leaders.

The need extends beyond scientists to include experienced business leaders.

Skills Gaps and Industry Needs

A recent survey of Toronto-area companies revealed significant shortages of senior executives, managers, and specialized scientists in areas like biomedical engineering and regenerative medicine.

These professionals often gravitate towards the higher compensation and opportunities available in U.S. industries.

At a recent summit of Canada’s Innovation Economy Council (IEC), leaders discussed unfilled positions in regulatory affairs, business development, and even chief medical officer roles.

These positions require a unique combination of technical expertise and business acumen, developed through both academic training and progressive leadership experience.

Addressing the Talent Gap

Canadian universities, innovation hubs, and venture capital firms are responding by establishing specialized training programs. Scaling companies are leveraging their recent funding to actively recruit from the U.S. and other international markets.

They are offering remote work options, flexible hours, and forging partnerships to tap into previously unexplored talent pools.

Government Investment and Budgetary Commitments

Canada’s federal government recently unveiled its first comprehensive budget in two years, featuring one of the most ambitious tech-spending plans in the nation’s history.

This demonstrates the government’s commitment to developing advanced industries and creating STEM jobs, particularly as global markets shift away from Canada’s traditional reliance on energy exports, natural resources, and manufactured goods.

The budget includes research partnerships, hiring subsidies, grants, and support for incubators and hubs. A significant $2.2 billion is dedicated to building a robust life-sciences talent pipeline.

Public Support for Investment

Public opinion in Canada generally supports government spending to combat COVID-19 and facilitate the transition to a new economy.

An IEC/Campaign Research poll in early April indicated a 3:1 public approval ratio for investments in postsecondary STEM education and similar strong support for government investment in advanced manufacturing, including biotechnology.

This level of support is crucial for competing with a nation ten times its size.

A Realistic Outlook and Growing Appeal

While Canada is unlikely to completely deplete the U.S. of its research scientists and pharmaceutical executives in the near future, the influx of investment capital, a thriving tech ecosystem, and a focused policy effort to build, recruit, and retain talent are positioning Canada as an increasingly attractive destination for the industry.

In essence, the United States should be aware that Canada is proactively working to attract biotechnology talent.